| Safety of Remibrutinib Across Immune-mediated Diseases Supports Development in Multiple Sclerosis (P8-6.015) B Kieseier, X Montalban, M Williams, L Airas, S Saini, M Hide, G Sussman, ... Neurology 102 (17_supplement_1), 3084, 2024 | | 2024 |
| A review of Bruton’s tyrosine kinase inhibitors in multiple sclerosis L Airas, RA Bermel, T Chitnis, HP Hartung, J Nakahara, O Stuve, ... Therapeutic Advances in Neurological Disorders 17, 17562864241233041, 2024 | 1 | 2024 |
| P2X7-receptor binding in new-onset and secondary progressive MS–a [11C] SMW139 PET study J Lehto, R Aarnio, J Tuisku, M Sucksdorff, EM Koivumäki, M Nylund, ... | | 2024 |
| Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals S Laaksonen, M Saraste, M Nylund, R Hinz, A Snellman, J Rinne, ... Frontiers in Neurology 15, 1352116, 2024 | | 2024 |
| Sex-driven variability in S Laaksonen, M Saraste, M Nylund, R Hinz, A Snellman, J Rinne, ... | | 2024 |
| Phase 3 REMODEL I/II Trials: Efficacy, Safety, and Tolerability of Remibrutinib in Patients with Relapsing Multiple Sclerosis H Wiendl, L Airas, T Chitnis, M Williams, J Nakahara, R Bermel, B Loop, ... Multiple Sclerosis and Related Disorders 80, 105315, 2023 | | 2023 |
| Neuroimaging to monitor worsening of multiple sclerosis: advances supported by the grant for multiple sclerosis innovation J Oh, L Airas, D Harrison, E Järvinen, T Livingston, S Lanker, RA Malik, ... Frontiers in Neurology 14, 1319869, 2023 | | 2023 |
| An International Consensus with Delphi Methodology on Smoldering Disease in MS: Definition, Clinical Manifestations and Underlying Biology A Scalfari, F Bagnato, J Oh, L Airas, S Bittner, M Calabrese, ... MULTIPLE SCLEROSIS JOURNAL 29, 421-421, 2023 | | 2023 |
| PET-based characterization of the broad rim lesion, a novel progression-related lesion phenotype J Lehto, M Matilainen, L Klotz, T Kuhlmann, L Airas MULTIPLE SCLEROSIS JOURNAL 29, 10-11, 2023 | | 2023 |
| Usability of TSPO-PET-imaging in evaluation of risk of secondary progression in MS S Laaksonen, M Matilainen, L Airas MULTIPLE SCLEROSIS JOURNAL 29, 524-524, 2023 | | 2023 |
| Evolution of smouldering inflammation throughout MS disease course M Matilainen, L Airas MULTIPLE SCLEROSIS JOURNAL 29, 17-17, 2023 | | 2023 |
| Assessment of microglia phenotype in multiple sclerosis using patient-derived induced pluripotent stem cells T Hyvarinen, J Lotila, I Tujula, H Jantti, S Ohtonen, H Skottman, L Airas, ... MULTIPLE SCLEROSIS JOURNAL 29, 215-215, 2023 | | 2023 |
| A longitudinal positron emission tomography study of smoldering inflammation in untreated multiple sclerosis M Nylund, J Lehto, M Matilainen, L Airas MULTIPLE SCLEROSIS JOURNAL 29, 99-99, 2023 | | 2023 |
| Broad perilesional rim of macrophages/microglia as biomarker for rapid MS disease progression L Klotz, J Smolders, J Lehto, M Matilainen, A Van den Bosch, L Airas, ... MULTIPLE SCLEROSIS JOURNAL 29, 18-19, 2023 | | 2023 |
| The relevance of interactions between NF-kappaB risk allele rs7665090, astrocytic activation and development of chronic lesions in multiple sclerosis-an in vivo PET and MRI study M Saraste, P Miettinen, M Matilainen, D Pitt, L Airas MULTIPLE SCLEROSIS JOURNAL 29, 272-272, 2023 | | 2023 |
| Remibrutinib, a Novel, Highly Selective and Potent BTKi in Development for MS: Analysis of Safety Data From the Completed Phase 2 Studies in Other Inflammatory Immune-Mediated … T Chitnis, M Williams, L Airas, S Saini, M Hide, G Sussman, J Nakahara, ... MULTIPLE SCLEROSIS JOURNAL 29, 932-934, 2023 | | 2023 |
| Association of serum neurofilament light with microglial activation in multiple sclerosis M Saraste, M Matilainen, A Vuorimaa, S Laaksonen, M Sucksdorff, ... Journal of Neurology, Neurosurgery & Psychiatry 94 (9), 698-706, 2023 | 2 | 2023 |
| Reply from the author L Airas | | 2023 |
| Adenosine A2A receptor availability in cerebral gray and white matter of patients with Parkinson's disease I Waggan, E Rissanen, J Tuisku, M Matilainen, R Parkkola, JO Rinne, ... Parkinsonism & Related Disorders 113, 105766, 2023 | | 2023 |
| Longitudinal stability of progression‐related microglial activity during teriflunomide treatment in patients with multiple sclerosis J Lehto, M Nylund, M Matilainen, M Sucksdorff, A Vuorimaa, J Rajander, ... European Journal of Neurology 30 (8), 2365-2375, 2023 | 2 | 2023 |
